Agenus

Today is World Pancreatic Cancer Day and Agenus is proud to join Pancreatic Cancer Action Network in raising awareness of #PancreaticCancer. Early detection is critical to increasing survival, but currently there is no standard test to find pancreatic cancer early. Learn more about the steps everyone can take to be proactive about their health: pancan.org/awareness #PanCANawareness

Today we announced our third-quarter financial results and shared a corporate update. Discover the latest progress and insights from this quarter here: https://bit.ly/40Modjl

At #SITC24 we are presenting new data from our investigational immunotherapy programs, including botensilimab and AGEN1721. Explore our latest advancements in cancer research here: https://bit.ly/3ClYdBq

This past weekend, Agenus was proud to support Colorectal Cancer Alliance’s National Blue Hope Bash, a gathering of passionate allies committed to raising awareness and support for #colorectalcancer research and advocacy. 

Receiving a #cancer diagnosis can be overwhelming and filled with uncertainties. We’re here to share knowledge, including providing you with information about our research in #immunotherapy, finding clinical trials, and more: https://bit.ly/4gDOAxw

Meet Dhan Chand, our Vice President of Research. Dhan believes that innovation comes from questioning the norm, taking risks, and inspiring others to embrace unconventional ideas. Reflecting on his career, Dhan shares, "I used to feel like a small cog in a big machine, unsure of my ability to create meaningful change. But I learned that even the smallest actions, like offering a suggestion or supporting a colleague, can spark significant improvements."    Dhan says the collaborative spirit at Agenus is unmatched and he’s inspired by being part of a team that strives to make a real difference in patients’ lives. “These shared experiences are invaluable,” he says. “They ground me in the beautiful complexity of our world and reinforce the importance of human connections.” 

Thank you, STAT, for another great summit! Our team enjoyed hearing from some of the top voices in the industry, as well as policymakers and advocates. We were proud to sponsor this year’s event and have our Chief Medical Officer, Dr. Steven O'Day, share his insights on cancer #immunotherapy.  #STATSummit 

Agenus has arrived at the #STATSummit! We’re looking forward to Dr. Steven O'Day’s Eureka Moment talk: “Rethinking How We Measure Cancer Immunotherapies,” which will explore how traditional metrics of tumor response often fail to capture the full benefits cancer #immunotherapy can provide.

We’re on a mission to harness the power of the immune system to bring therapies to individuals living with #cancer. Celebrate 30 years of innovation with us and learn more about our history: https://bit.ly/47mOYw4 

We’re excited to congratulate our Chairman & CEO, Dr. Garo Armen, on receiving WITSA’s Eminent Person Award. This recognition is a testament to his leadership and commitment to advancing #immunotherapy. We’re grateful to WITSA for honoring the impact his work continues to have on improving patients’ lives.